Form: 10-K

Annual report pursuant to Section 13 and 15(d)

June 21, 2022

img205659619_0.jpg 

 

KPMG LLP
600 de Maisonneuve Blvd West

Suite 1500, Tour KPMG

Montréal (Québec) H3A 0A3

Tel. 514-840-2100

Fax. 514-840-2187

www.kpmg.ca

 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the registration statements (No. 333-191383 and No. 333-227476) on Form S-8 and (No. 333-239538) on Form S-3 of Acasti Pharma Inc. of our report dated June 21, 2022, with respect to the consolidated balance sheets of Acasti Pharma Inc. as of March 31, 2022 and 2021, the related consolidated statements of loss and comprehensive loss, changes in shareholders’ equity and cash flows for the years ended March 31, 2022 and 2021, and the related notes.

 

 

 

 

img205659619_1.jpg 


 

Montréal, Québec

June 21, 2022

 

 

© 2022 KPMG LLP, an Ontario limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved